Sectoral Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Sectoral Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$343K	Sell	15,680 -16,000	-51%	-$333K	0.24%	68
2026 Q1	$787K	Sell	31,680 -29,520	-48%	-$641K	0.65%	39
2025 Q4	$1.29M	Sell	61,200 -18,230	-23%	-$318K	1.03%	29
2025 Q3	$1.22M	Buy	79,430 +16,130	+25%	+$211K	0.75%	46
2025 Q2	$593K	Buy	+63,300	New	+$697K	0.39%	65
2024 Q1	–	Sell	-92,060	Closed	-$1.99M	–	107
2023 Q4	$1.99M	Buy	+92,060	New	+$1.42M	0.86%	43

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Sectoral Asset Management's SNDX Position: Q2 2026 in Review

Sectoral Asset Management reduced its Syndax Pharmaceuticals (SNDX) stake by 51% in Q2 2026, selling an estimated $333K and leaving 15,680 shares worth $343K. The position accounts for 0.24% of the portfolio, ranked #68.

Sectoral Asset Management first reported a position in SNDX in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.99M in Q4 2023. 243 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

Sectoral Asset Management held 15,680 shares of Syndax Pharmaceuticals worth $343K as of Q2 2026.
Sectoral Asset Management sold 16,000 Syndax Pharmaceuticals shares in Q2 2026, an estimated $333K.
Syndax Pharmaceuticals made up 0.24% of Sectoral Asset Management's portfolio in Q2 2026, its #68 holding.
Sectoral Asset Management first reported a position in Syndax Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
Sectoral Asset Management's Syndax Pharmaceuticals position peaked at $1.99M in Q4 2023.
243 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.